Efficacy of Fibrin Glue in Skin Grafts for Skin Cancer (FiGSS): Open Randomised Clinical Trial

Paw, Ekta, Vangaveti, Venkat, and Heal, Clare (2026) Efficacy of Fibrin Glue in Skin Grafts for Skin Cancer (FiGSS): Open Randomised Clinical Trial. Annals of Surgical Oncology. (In Press)

[img]
Preview
PDF (Publisher Accepted Version) - Published Version
Available under License Creative Commons Attribution.

Download (891kB) | Preview
View at Publisher Website: https://doi.org/10.1245/s10434-026-19428...
 
1


Abstract

Background This study aimed to conduct the first randomized clinical trial on the use of fibrin glue in split-skin grafts for skin cancer. Fibrin glue is an accepted technique for affixing split-skin grafts. Evidence suggests that fibrin glue has greater effectiveness than sutures or staples, particularly in populations with more comorbidities.

Methods This randomized controlled clinical trial was conducted at a regional center in Queensland, Australia across the only two major hospitals in the area. The primary outcome assessed was graft take 1 month postoperatively. Pain with dressing changes and incidence of seroma, hematoma, and infection as well as operative time were assessed as secondary outcomes. Patients were recruited and randomized to either fibrin glue or staples and sutures for graft affixation. They were subsequently followed up at 1 week and 1 month for outcome assessment.

Results The study recruited 100 patients, and 83 patients with 133 grafts were analyzed for outcomes. Fibrin glue increased graft take by 17.13% when the study controlled for other variables. However, this was not statistically significant (p = 0.058; confidence interval [CI] − 0.63 to 34.89). There was a statistically significant reduction in the odds of seroma (odds ratio [OR] 0.08; CI 0.01–0.50; p < 0.01) and infection (OR 0.04; CI 0.00–0.33; p < 0.01) at 1 week.

Conclusions Fibrin glue may be of benefit for patients at higher risk for graft failure and is likely to benefit patients at increased risk of seroma and infection.

Trial registration ANZCTR: ACTRN12618000484246.

Item ID: 90984
Item Type: Article (Research - C1)
ISSN: 1534-4681
Copyright Information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Date Deposited: 17 Mar 2026 02:58
FoR Codes: 32 BIOMEDICAL AND CLINICAL SCIENCES > 3202 Clinical sciences > 320226 Surgery @ 100%
SEO Codes: 20 HEALTH > 2003 Provision of health and support services > 200304 Inpatient hospital care @ 100%
Downloads: Total: 1
Last 12 Months: 1
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page